Psychemedics Statistics
Total Valuation
Psychemedics has a market cap or net worth of $13.79 million. The enterprise value is $13.97 million.
Important Dates
The last earnings date was Tuesday, November 12, 2024, after market close.
| Earnings Date | Nov 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Psychemedics has 5.89 million shares outstanding. The number of shares has increased by 2.05% in one year.
| Current Share Class | 5.89M |
| Shares Outstanding | 5.89M |
| Shares Change (YoY) | +2.05% |
| Shares Change (QoQ) | +1.32% |
| Owned by Insiders (%) | 20.04% |
| Owned by Institutions (%) | 21.70% |
| Float | 4.38M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.67 |
| Forward PS | n/a |
| PB Ratio | 2.53 |
| P/TBV Ratio | 2.53 |
| P/FCF Ratio | 27.98 |
| P/OCF Ratio | 24.11 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.69 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 28.33 |
Financial Position
The company has a current ratio of 1.59, with a Debt / Equity ratio of 0.29.
| Current Ratio | 1.59 |
| Quick Ratio | 1.25 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | n/a |
| Debt / FCF | 3.20 |
| Interest Coverage | -86.15 |
Financial Efficiency
Return on equity (ROE) is -46.52% and return on invested capital (ROIC) is -21.41%.
| Return on Equity (ROE) | -46.52% |
| Return on Assets (ROA) | -15.29% |
| Return on Capital (ROIC) | -21.41% |
| Revenue Per Employee | $174,638 |
| Profits Per Employee | -$25,819 |
| Employee Count | 116 |
| Asset Turnover | 1.69 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Psychemedics has paid $43,000 in taxes.
| Income Tax | 43,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +10.17% in the last 52 weeks. The beta is 0.67, so Psychemedics's price volatility has been lower than the market average.
| Beta (5Y) | 0.67 |
| 52-Week Price Change | +10.17% |
| 50-Day Moving Average | 2.32 |
| 200-Day Moving Average | 2.49 |
| Relative Strength Index (RSI) | 54.46 |
| Average Volume (20 Days) | 25,100 |
Short Selling Information
The latest short interest is 13,847, so 0.23% of the outstanding shares have been sold short.
| Short Interest | 13,847 |
| Short Previous Month | 24,504 |
| Short % of Shares Out | 0.23% |
| Short % of Float | 0.32% |
| Short Ratio (days to cover) | 0.79 |
Income Statement
In the last 12 months, Psychemedics had revenue of $20.26 million and -$3.00 million in losses. Loss per share was -$0.51.
| Revenue | 20.26M |
| Gross Profit | 7.77M |
| Operating Income | -2.93M |
| Pretax Income | -3.48M |
| Net Income | -3.00M |
| EBITDA | -1.89M |
| EBIT | -2.93M |
| Loss Per Share | -$0.51 |
Full Income StatementBalance Sheet
The company has $1.41 million in cash and $1.58 million in debt, giving a net cash position of -$174,000 or -$0.03 per share.
| Cash & Cash Equivalents | 1.41M |
| Total Debt | 1.58M |
| Net Cash | -174,000 |
| Net Cash Per Share | -$0.03 |
| Equity (Book Value) | 5.45M |
| Book Value Per Share | 0.92 |
| Working Capital | 2.25M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $572,000 and capital expenditures -$79,000, giving a free cash flow of $493,000.
| Operating Cash Flow | 572,000 |
| Capital Expenditures | -79,000 |
| Free Cash Flow | 493,000 |
| FCF Per Share | $0.08 |
Full Cash Flow StatementMargins
Gross margin is 38.36%, with operating and profit margins of -14.46% and -14.78%.
| Gross Margin | 38.36% |
| Operating Margin | -14.46% |
| Pretax Margin | -14.57% |
| Profit Margin | -14.78% |
| EBITDA Margin | -9.31% |
| EBIT Margin | -14.46% |
| FCF Margin | -8.58% |